FDA Orange Book
Have a question about this Dataset?
Our AI-powered search engine is continually improving.Learn more
FDA Orange Book is one of three datasets offered by S&P Global Market Intelligence from the U.S. Food and Drug Administration (FDA). The FDA Orange Book identifies drug products approved on the basis of safety and effectiveness by the FDA. Relates a named drug to a set of compounds and to the drug owner.
Vendor information
At S&P Global Market Intelligence, we understand the importance of accurate, deep and insightful information. Our team of experts delivers unrivaled insights and leading data and technology solutions, partnering with customers to expand their perspective, operate with confidence, and make decisions with conviction.
- Primary Entity TypeCompany
- Coverage Count50,000
- Geographic CoverageUnited States and Canada
- Industry CoverageHealthcare
- History Initiated2001
- Earliest Significant Coverage2001
- Point In TimeNo
- Data SourceFDA.gov
- Field Count10s
- Delivery ChannelFeed
- Delivery PlatformMarketplace Workbench, Xpressfeed™
- Reporting FrequencyMonthly
- Dataset LatencyMonthly